Extracorporeal membrane oxygenation (ECMO) was found to show overall favorable outcomes among cardiac patient survivors, who were treated in their childhood, reveals a new study.
ECMO provides short-term breathing and heart support for critically ill children while doctors treat the underlying illness.
ECMO Plays Critical Role in the Healthcare Sector
Recently, a leading hospital in Gurugram has claimed to have saved lives of highest number of people using ECMO (Extracorporeal membrane oxygenation).
Advertisement
‘Children with cardiac problems who were treated with Extracorporeal membrane oxygenation (ECMO) during their childhood showed favorable outcomes later in life.’
Tweet it Now
A research team from Children's Hospital of Philadelphia (CHOP) published the ECMO study in the issue of Pediatric Critical Care Medicine.
The team analyzed a cohort of 396 patients with cardiac disease treated with ECMO at CHOP from 1995 to 2012. Overall mortality was 66 percent at a median follow-up of 6 years after ECMO therapy, which remains consistent with outcomes seen in previous decades.
![ECMO Technique Saves a Baby Suffering From Rare Lung Disease]( "ECMO Technique Saves a Baby Suffering From Rare Lung Disease")
Extracorporeal Membrane Oxygenation (ECMO) treatment is a technique in which the blood circulates outside of the body with the help of a machine.
In phone surveys or written surveys among the families of survivors, a majority reported positive outcomes regarding health and physical limitations. Over 90 percent of families reported good or excellent health, and approximately 86 percent reported no or mild physical limitations.
However, the authors noted a discrepancy between family-reported favorable outcomes and a relatively high rate of medical and behavioral issues revealed by more detailed questioning.
Almost 25 percent of patients had below-average school performance and required special education, and almost 50 percent had parental-reported learning disabilities. These results may help families define realistic expectations regarding long-term outcomes for children supported with ECMO due to an underlying cardiac condition.
Matthew D. Elias, MD, a pediatric cardiologist at CHOP and first author of the study, noted that ECMO use in children with congenital heart disease (CHD) has increased markedly over the past several decades, as increased experience in pediatric cardiology and cardiac surgery has allowed ECMO use to expand to more complex patients.
Senior author Matthew J. O'Connor, MD, also a CHOP pediatric cardiologist, added that "several factors have potentially improved long-term outcomes, such as increasing experience with ECMO and CHD in general. But the inclusion of a more medically complex population in the recent era may mitigate these improvements in outcomes, accounting for the fact that overall mortality rates haven't changed much."
Although this single-center study represents one of the largest cohorts of ECMO patients undergoing detailed assessments of outcomes and quality of life, Elias said that further research in larger, multicenter studies should further investigate family experiences and long-term patient outcomes.
He added, "In the meantime, our findings should allow for improved family counseling in discussing long-term quality-of-life for children with heart disease."
Source: Eurekalert
ECMO Technique Saves a Baby Suffering From Rare Lung Disease
Extracorporeal Membrane Oxygenation (ECMO) treatment is a technique in which the blood circulates outside of the body with the help of a machine.
Advertisement
In phone surveys or written surveys among the families of survivors, a majority reported positive outcomes regarding health and physical limitations. Over 90 percent of families reported good or excellent health, and approximately 86 percent reported no or mild physical limitations.
However, the authors noted a discrepancy between family-reported favorable outcomes and a relatively high rate of medical and behavioral issues revealed by more detailed questioning.
Almost 25 percent of patients had below-average school performance and required special education, and almost 50 percent had parental-reported learning disabilities. These results may help families define realistic expectations regarding long-term outcomes for children supported with ECMO due to an underlying cardiac condition.
Matthew D. Elias, MD, a pediatric cardiologist at CHOP and first author of the study, noted that ECMO use in children with congenital heart disease (CHD) has increased markedly over the past several decades, as increased experience in pediatric cardiology and cardiac surgery has allowed ECMO use to expand to more complex patients.
Senior author Matthew J. O'Connor, MD, also a CHOP pediatric cardiologist, added that "several factors have potentially improved long-term outcomes, such as increasing experience with ECMO and CHD in general. But the inclusion of a more medically complex population in the recent era may mitigate these improvements in outcomes, accounting for the fact that overall mortality rates haven't changed much."
Although this single-center study represents one of the largest cohorts of ECMO patients undergoing detailed assessments of outcomes and quality of life, Elias said that further research in larger, multicenter studies should further investigate family experiences and long-term patient outcomes.
He added, "In the meantime, our findings should allow for improved family counseling in discussing long-term quality-of-life for children with heart disease."
Source: Eurekalert
ECMO may Now be Used to Treat Cardiac Arrest
Extracorporeal membrane oxygenation- a procedure used during cardiac surgeries have now been used to resuscitate cardiac arrest patients in Japan, Taiwan and South Korea
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Child Health News
Playing in early childhood is key to shaping a healthier brain, as emphasized by a top expert.
Side-effects of valproate drug taken during pregnancy, enhance the expression of Rnf146 gene, causing autism spectrum disorder in fetus.
Children with amblyopia or lazy eye who underwent digital vision training, showed no appreciable improvement in their eyesight.
In 2022, over 20% of children worldwide lacked adequate calories for growth, with 45+ million showing wasting (underweight for height).
After PCV7 licensure, pneumococcal infection rates in children aged 5+ with sickle cell disease significantly decreased.
